Medtronic Next To Try Inversion Despite Political Blowback
Medtronic Inc.'s $42.9 billion merger with rival Covidien PLC, unveiled Sunday, makes it one of the biggest U.S. firms to pursue a transaction that would shift its legal home to tax-friendly...To view the full article, register now.
Already a subscriber? Click here to view full article